Calumet: Shorts Are At Risk

Calumet Specialty Products (CLMT) reported better-than-expected June results, driven by strong quarterly performance, robust cost controls, and positive contributions from both specialty and renewable segments. Notably, its Montana Renewables (MRL) unit achieved industry-leading, unprecedented breakeven costs and positive EBITDA despite a challenging renewable fuels market. Looking ahead, catalysts such as the MaxSAF-150 project and a higher EPA RVO are expected to drive significant cash flow and margin expansion by 2026, potentially triggering a substantial stock price rally given high short interest and diminishing operational risks.

Analysis

Calumet Specialty Products (CLMT) reported June quarter results that surpassed expectations, driven by robust cost controls and positive performance in both its specialty and renewable diesel segments. The key driver of this outperformance is the Montana Renewables (MRL) unit, which achieved positive EBITDA and guided towards unprecedented, industry-leading breakeven costs despite a challenging market for renewable fuels. This operational strength positions CLMT as a top-tier operator. Looking forward, the company's outlook is supported by specific catalysts, including the MaxSAF-150 project and an anticipated increase in the EPA's Renewable Volume Obligation (RVO), which are projected to fuel significant cash flow and margin expansion by 2026. This bullish fundamental and operational picture is set against a backdrop of record-high short interest, creating a potential scenario for a short squeeze, particularly if the stock price moves above the $17 level noted in the report.

Key Decisions for Investors

• Investors should evaluate CLMT's operational execution, particularly MRL's best-in-class cost structure, as a potential durable advantage in the competitive renewable fuels sector.
• Given the record-high short interest, market participants should monitor trading volumes and price action around the $17 technical level, as a breakout could serve as a trigger for a significant short squeeze.
• The long-term investment thesis hinges on future catalysts; therefore, it is critical to track progress on the MaxSAF-150 project and any regulatory updates to the EPA's RVO, which are key to the projected 2026 margin expansion.